KATHRYN WAKELAND: Open Payments
NPI 1184342339 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,986 in 133 payments from 28 companies in 2025. Trend: 2023 $528 · 2024 $2,123 · 2025 $25,986
Speaker / faculty: $23,227Food & beverage: $2,735Education: $24
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 24 | $23,490 |
| Neurocrine BioSciences, Inc. | 10 | $343 |
| Xeris Pharmaceuticals, Inc. | 13 | $318 |
| Novo Nordisk Inc | 14 | $303 |
| Sequel Med Tech, LLC | 9 | $180 |
| Dexcom, Inc. | 8 | $178 |
| Lilly USA, LLC | 10 | $145 |
| SANOFI-AVENTIS U.S. LLC | 4 | $132 |
| Tandem Diabetes Care, Inc. | 6 | $102 |
| Corcept Therapeutics | 3 | $94 |
Products named: OMNIPOD, CRENESSITY, Ozempic, RECORLEV, TWIIST, Dexcom G6 Transmitter, TZIELD, MOUNJARO.
Industry payments across TX — which companies pay providers there.
